Controversies in Skin Testing for Allergic Rhinitis

Purpose of Review This article will review different methods of skin testing available for allergic rhinitis, emphasizing controversies and challenges associated with these techniques. Recent Findings The utility of quantitative skin testing has been debated in current literature, as has the accurac...

Full description

Saved in:
Bibliographic Details
Published inCurrent otorhinolaryngology reports Vol. 8; no. 2; pp. 175 - 184
Main Authors Watley, Duncan C., Haroun, Kareem B., Siddiqui, Farrah N.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2020
Subjects
Medicine
Medicine & Public Health
Otolaryngic Allergy
Otolaryngic Allergy (SK Wise and C Damask
Otorhinolaryngology
Section Editors
Intradermal testing
Inhalant allergy
Allergy controversy
Allergic rhinitis
Skin prick testing
Modified quantitative testing
Online AccessGet full text

Cover

More Information
Summary:Purpose of Review This article will review different methods of skin testing available for allergic rhinitis, emphasizing controversies and challenges associated with these techniques. Recent Findings The utility of quantitative skin testing has been debated in current literature, as has the accuracy of skin versus in vitro testing. Single- and pauci-allergen immunotherapy (AIT) have also shown good outcomes, thus questioning the use of large testing panels. Recent studies further support the use of standardized and recombinant antigens. Summary Skin testing remains a safe and dependable tool in the diagnosis and management of allergic rhinitis. Newer techniques such as component-resolved diagnostics (CRD), recombinant antigens, and enhanced skin evaluation are being studied, but are still expensive and not widely available. Areas that require more research include designing standardized and recombinant allergens, the real utility of quantitative skin testing, the number of aeroallergens to test and treat, skin testing for molds as well as when to repeat skin testing.
ISSN:2167-583X
2167-583X
DOI:10.1007/s40136-020-00284-9